Eurofins Scientific SE (EPA:ERF)

Market Cap	12.03B +33.9%
Revenue (ttm)	7.30B +5.0%
Net Income	416.00M +16.9%
EPS	2.23 +21.9%
Shares Out	176.59M
PE Ratio	30.56
Forward PE	16.45
Dividend	0.72 (1.09%)
Ex-Dividend Date	Apr 28, 2025

Volume	408,396
Average Volume	349,088
Open	65.94
Previous Close	66.20
Day's Range	65.78 - 68.14
52-Week Range	45.56 - 74.32
Beta	0.90
RSI	50.66
Earnings Date	Jan 29, 2026

About Eurofins Scientific SE

Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. It provides services, such as agroscience, including biological assessment, consumer and human, environmental safety, product chemistry, regulatory consultancy, and seed services; agro testing; assurance, including sustainability, audit, certification, quality inspection, training, advisory, and labelling services; biopharma, and clinical diagnostics. The company also offers consumer product testing, which include susta...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1987
• Employees: 65,000
• Stock Exchange: Euronext Paris
• Ticker Symbol: ERF

Financial Performance

In 2025, Eurofins Scientific SE's revenue was 7.30 billion, an increase of 4.96% compared to the previous year's 6.95 billion. Earnings were 416.00 million, an increase of 16.76%.